You are here: Industry Insights > Drugs

News List

Mixed results from Roche’s key new drugs in Q1 pharmaphorum
April 27, 2018
Roche is relying on new drugs such as Ocrevus for multiple sclerosis and cancer drug Tecentriq to recoup sales as its big three blockbuster drugs are facing generic competition.
Boehringer Ingelheim posts 5-percent sales growth for prescription drugs in 2017; provides R&D update firstwordpharma
April 26, 2018
Boehringer Ingelheim reported Wednesday that sales of prescription medicines in 2017 rose 5 percent year-over-year to 12.6 billion euros ($15.4 billion), with six medicines generating revenue of over $1 billion.
Amazon shelves plans to sell drugs to hospitals pharmaphorum
April 20, 2018
Amazon has reportedly shelved a plan to sell drugs to hospitals as it deemed the logistics operation necessary would be too complex, according to a press report.
Study reveals "concerning" low standards of type 2 diabetes drugs in India pharmafile
March 08, 2018
The Indian regulatory system, particularly type 2 diabetes, allows the use of drugs that have not been proven to be safe and effective, far behind the standards set by the World Health Organization.
World's Top 5 Best-Selling Drugs in 2017 biospace
December 19, 2017
The five top-selling drugs brought in a combined $48 billion so far this year
Tiny Corbus Aims to Have Four Drugs in Mid- to Late-Stage Development by Next Year biospace
November 22, 2017
In less than four years, Corbus Pharmaceuticals has grown from a tiny startup to a public company with 60 employees and four assets in the clinic.
Pfizer in fight with states over their intent to use its drugs for executions fiercepharma
November 21, 2017
Pfizer is in a tug of war with several states that intend to use some of its drugs to carry out executions.
Congress Weighs Repeal of Tax Credit for Rare Disease Drugs nytimes
November 09, 2017
A decades-old tax credit designed to spur cures for rare diseases has been so successful that it’s now become a target in the House Republican tax plan.
TB Alliance declares potential of two novel TB drugs biospectrumasia
October 13, 2017
Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration.
Engineering approach combines drugs to control parasitic worms europeanpharmaceuticalreview
October 09, 2017
Researchers have developed a technology – that can quickly identify potential drug combinations to control parasitic worms…

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page